Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Aronora, Inc.
United States
- Portland, Oregon
- 16/10/2023
- Unknown
- Undisclosed Amount
Aronora is a translational biotechnology company (aronorabio.com) engaged in the development of proprietary biologic therapeutics, including recombinant monolconal antibodies and enzymes.
Rational design of our innovative therapeutic agents is expected to result in drug products that reduce the progression and growth of life-threatening blood clots without the detrimental bleeding side effects that characterize all currently marketed antithrombotic drugs. Our products are intended to be used in difficult-to-treat, severe, rapidly progressing, or catastrophic thrombotic blood clotting diseases.
- Industry Pharmaceutical Manufacturing
- Website https://aronorabio.com/
- LinkedIn https://www.linkedin.com/company/aronora/about/
Related People
Erik TuckerFounder
United States -
Portland, Oregon
Talented scientist and entrepreneur, having led his team from product discovery to two INDs and four successful clinical trials. Has more than 90 U.S. and international patents, authored >40 scientific articles, and raised significant non-dilutive funding through a combination of small business grants from the National Institutes of Health SBIR program, a strategic alliance with Bayer, and a royalty monetization deal with XOMA Corporation. Also an experienced angel investor, federal grant reviewer, and bioscience mentor.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)